Study Identifies Risk Factors for Primary AVF Dysfunction in HD
High platelet counts and anemia are among the risk factors for arteriovenous fistula dysfunction in patients on hemodialysis.
Hemodialysis
Upper Arm AVFs May Be the Better Option for Patients Initiating HD
In a study, upper arm arteriovenous fistulas were associated with better hemodialysis access survival.
Clinical Parameters Interrelate Prior to Dialysis
The interdependence of trajectories in patient parameters, such as albumin and white blood cell count, may suggest certain disease processes.
CRBSI Clinical Presentation Varies by Causative Pathogen
Patients with Staphylococcus aureus catheter-related bloodstream infections are the most likely to present with fever, rigor, or both, a study found.
Mortality Rate Lower With Arteriovenous Fistulas
Patients receiving hemodialysis with arteriovenous fistulas vs central venous catheters are less likely to die or be hospitalized.
High TSH Linked With Endothelial Dysfunction in HD
In a small study of hemodialysis patients, the highest 3 quartiles of serum thyrotropin were associated with nearly triple the risks for worse endothelial function.
Bleeding Risk Outweighs Stroke Risk in ESRD Patients With AFib
Even a low HAS-BLED score of 0 was associated with high risk for bleeding in this population: 5.6 per 100 patient-years.
More Than Half of Older Patients Die Within 1 Year of Starting Dialysis
In a study, 54.5% of Medicare patients died within 1 year of dialysis initiation, a mortality rate much higher than calculated by the US Renal Data System.
Trial Results Unclear for Benefit of Longer Hemodialysis Sessions
Intervention uptake not sufficient to assess impact of longer hemodialysis sessions on patient outcomes
Canagliflozin Lowers ESRD Risk in Diabetic Kidney Disease
In a study of patients with type 2 diabetes and chronic kidney disease, canagliflozin, an SGLT2 inhibitor, decreased the risk of end-stage renal disease by 32% compared with placebo.
Next post in Chronic Kidney Disease (CKD)
